Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Debraj Mukherjee

Showing results (181-190 of 277) with videos related to

Pageof 28
Sort By:
Journal of Neurosurgery. Spine|June 7, 2024
Fractionated radiotherapy after gross-total resection of spinal chordoma: a systematic review of survival outcomes using individualized patient dataJulian L Gendreau, Kritika Gowda, Foad Kazemi, et al.
World Neurosurgery|May 29, 2020
Impact of COVID-19 on an Academic Neurosurgery Department: The Johns Hopkins ExperienceAdham M Khalafallah, Adrian E Jimenez, Ryan P Lee, et al.
Neuro-Oncology|November 2, 2012
High levels of phosphorylated MAP kinase are associated with poor survival among patients with glioblastoma during the temozolomide eraChirag G Patil, Miriam Nuño, Adam Elramsisy, et al.
Journal of Neurosurgery|June 16, 2018
Prospective validation of a molecular prognostication panel for clival chordomaGeorgios A Zenonos, Juan C Fernandez-Miranda, Debraj Mukherjee, et al.
Neurosurgical Focus|August 1, 2025
The role of extent of resection, chemoradiation, and MGMT promoter methylation in overall survival in a large cohort of IDH-wildtype glioblastomaMegan Parker, Austin Carmichael, Antolin Serrano-Farias, et al.
Plos One|April 6, 2012
Loss of PTEN is not associated with poor survival in newly diagnosed glioblastoma patients of the temozolomide eraChristine Carico, Miriam Nuño, Debraj Mukherjee, et al.
World Neurosurgery|February 23, 2022
Novel Predictive Models for High-Value Care Outcomes Following Glioblastoma ResectionSumil K Nair, Sachiv Chakravarti, Adrian E Jimenez, et al.
Journal of Neurosurgery|March 30, 2022
Social determinants of health and the prediction of 90-day mortality among brain tumor patientsAdrian E Jimenez, Kyle V Cicalese, Sachiv Chakravarti, et al.
World Neurosurgery|March 13, 2023
Quality of Life in Chordoma Co-Survivors: Results from the Chordoma Foundation Survivorship SurveyAdrian E Jimenez, Kyle V Cicalese, Miguel A Jimenez, et al.
Neurosurgical Focus|May 1, 2024
Quality of life in chordoma survivors: results from the Chordoma Foundation Survivorship SurveyAdrian E Jimenez, Kyle V Cicalese, Miguel A Jimenez, et al.
Pageof 28

Showing results (181-190 of 277) with videos related to

Sort By:
Pageof 28
Journal of Neurosurgery. Spine|June 7, 2024
Fractionated radiotherapy after gross-total resection of spinal chordoma: a systematic review of survival outcomes using individualized patient dataJulian L Gendreau, Kritika Gowda, Foad Kazemi, et al.
World Neurosurgery|May 29, 2020
Impact of COVID-19 on an Academic Neurosurgery Department: The Johns Hopkins ExperienceAdham M Khalafallah, Adrian E Jimenez, Ryan P Lee, et al.
Neuro-Oncology|November 2, 2012
High levels of phosphorylated MAP kinase are associated with poor survival among patients with glioblastoma during the temozolomide eraChirag G Patil, Miriam Nuño, Adam Elramsisy, et al.
Journal of Neurosurgery|June 16, 2018
Prospective validation of a molecular prognostication panel for clival chordomaGeorgios A Zenonos, Juan C Fernandez-Miranda, Debraj Mukherjee, et al.
Neurosurgical Focus|August 1, 2025
The role of extent of resection, chemoradiation, and MGMT promoter methylation in overall survival in a large cohort of IDH-wildtype glioblastomaMegan Parker, Austin Carmichael, Antolin Serrano-Farias, et al.
Plos One|April 6, 2012
Loss of PTEN is not associated with poor survival in newly diagnosed glioblastoma patients of the temozolomide eraChristine Carico, Miriam Nuño, Debraj Mukherjee, et al.
World Neurosurgery|February 23, 2022
Novel Predictive Models for High-Value Care Outcomes Following Glioblastoma ResectionSumil K Nair, Sachiv Chakravarti, Adrian E Jimenez, et al.
Journal of Neurosurgery|March 30, 2022
Social determinants of health and the prediction of 90-day mortality among brain tumor patientsAdrian E Jimenez, Kyle V Cicalese, Sachiv Chakravarti, et al.
World Neurosurgery|March 13, 2023
Quality of Life in Chordoma Co-Survivors: Results from the Chordoma Foundation Survivorship SurveyAdrian E Jimenez, Kyle V Cicalese, Miguel A Jimenez, et al.
Neurosurgical Focus|May 1, 2024
Quality of life in chordoma survivors: results from the Chordoma Foundation Survivorship SurveyAdrian E Jimenez, Kyle V Cicalese, Miguel A Jimenez, et al.
Pageof 28